跳至主要内容
临床试验/JPRN-UMIN000044998
JPRN-UMIN000044998已完成未知

Physiological effects test by continuous intake of alcohol - Physiological effects test by continuous intake of alcohol

HUMA R&D CORP0 个研究点目标入组 42 人开始时间: 2021年7月30日最近更新:

试验速览

阶段
未知
状态
已完成
发起方
入组人数
42

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
40years-old 至 70years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1.Habitual drinkers (subject who drinks more than once a week on average in the last 3 months). 2.Subject who plans to have a health checkup and a human dock test during the test period. 3.Subject who is taking medication or under medical treatment due to serious illness. 4.Subject who is under exercise therapy or dietetic therapy. 5.Subject who may develop allergies (alcohol) due to the test foods. 6.Subject with current or history of alcohol and drug dependence. 7.Subject who is out of the hospital due to mental disorders (depression, etc.) or sleep disorders, or who has a history of mental illness in the past. 8.Subject with irregular life rhythms due to night shifts or shift work. 9.Subject with extremely irregular lifestyle habits such as eating and sleeping. 10.Subject who has an extremely unbalanced diet. 11.Subject who uses health foods, supplements, and medicines that affect alcohol metabolism. 12.Subject who has participated in other clinical studies within the past 3 months from the day of the consent acquisition or who is planning to participate in other clinical studies during the current study. 13.Subject who has blood collection or donation more than 200mL within the past 1 month or more than 400mL within the past 3 months from the day of the consent acquisition. 14.Subject who is planning to get pregnant after the day of informed consent or is currently pregnant and lactating. 15.Subject who has difficulty observing records on various survey forms. 16.Subject who is judged as an inappropriate candidate according to the screening data. 17.Subject who is considered as an inappropriate candidate by the doctor in charge.

研究者

发起方
HUMA R&D CORP

相似试验